Thursday, May 24, 2018

The drug, Aimovig, made by Amgen and Novartis, is a monthly injection with a device similar to an insulin pen. Aimovig blocks a protein fragment, CGRP, that instigates and perpetuates migraines

from Health https://ift.tt/2KQP9Eq

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner